Aspen Aerogels Files 8-K on Financials

TL;DR

Aspen Aerogels dropped an 8-K on May 1st detailing financials. Check it out.

AI Summary

On May 1, 2024, Aspen Aerogels, Inc. filed an 8-K report detailing its financial results and other relevant information. The filing includes financial statements and exhibits, providing insights into the company's operational and financial condition.

Why It Matters

This filing provides investors with crucial updates on Aspen Aerogels' financial performance and operational status, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not inherently introduce new risks.

Key Players & Entities

• Aspen Aerogels, Inc. (company) — Registrant
• May 01, 2024 (date) — Date of earliest event reported
• 001-36481 (company) — Commission File Number
• 04-3559972 (company) — IRS Employer Identification No.
• 30 Forbes Road Building B, Northborough, Massachusetts 01532 (company) — Principal Executive Offices
• (508) 691-1111 (company) — Registrant's Telephone Number

FAQ

Filing Documents

• f8k_050124.htm (8-K) — 21KB
• exh_991.htm (EX-99.1) — 102KB
• 0001171843-24-002426.txt ( ) — 307KB
• aspn-20240501.xsd (EX-101.SCH) — 3KB
• aspn-20240501_lab.xml (EX-101.LAB) — 33KB
• aspn-20240501_pre.xml (EX-101.PRE) — 22KB
• f8k_050124_htm.xml (XML) — 4KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On May 1, 2024, Aspen Aerogels, Inc. announced its financial results for the first quarter of 2024, which ended March 31, 2024, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading "2024 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking 8-K.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth under the heading "2024 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on May 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspen Aerogels, Inc. Date: May 1, 2024 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR